Exact Mass: 574.1001796

Exact Mass Matches: 574.1001796

Found 11 metabolites which its exact mass value is equals to given mass value 574.1001796, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Mangiferin 6'-gallate

[3,4,5-Trihydroxy-6-(1,3,6,7-tetrahydroxy-9-oxo-9H-xanthen-2-yl)oxan-2-yl]methyl 3,4,5-trihydroxybenzoic acid

C26H22O15 (574.0958662)


Mangiferin 6-gallate is found in fruits. Mangiferin 6-gallate is isolated from leaves of Mangifera indica (mango). Isolated from leaves of Mangifera indica (mango). Mangiferin 6-gallate is found in fruits.

   

Gadodiamide

3,13-bis(methylamino)-16,19,22-trioxo-2lambda4,14lambda4,15,20,23-pentaoxa-5lambda5,8lambda5,11lambda5-triaza-1-gadolinaheptacyclo[6.6.3.3^{1,5}.3^{1,11}.0^{1,5}.0^{1,8}.0^{1,11}]tricosa-2,13-diene-2,5,8,11,14-pentakis(ylium)-1-uide

C16H26GdN5O8 (574.1022406000001)


Gadodiamide is only found in individuals that have used or taken this drug. It is a gadolinium based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. It is commonly marketed under the trade name Omniscan. [Wikipedia]Based on the behavior of protons when placed in a strong magnetic field, which is interpreted and transformed into images by magnetic resonance (MR) instruments. Paramagnetic agents have unpaired electrons that generate a magnetic field about 700 times larger than the protons field, thus disturbing the protons local magnetic field. When the local magnetic field around a proton is disturbed, its relaxation process is altered. MR images are based on proton density and proton relaxation dynamics. MR instruments can record 2 different relaxation processes, the T1 (spin-lattice or longitudinal relaxation time) and the T2 (spin-spin or transverse relaxation time). In magnetic resonance imaging (MRI), visualization of normal and pathological brain tissue depends in part on variations in the radiofrequency signal intensity that occur with changes in proton density, alteration of the T1, and variation in the T2. When placed in a magnetic field, gadodiamide shortens both the T1 and the T2 relaxation times in tissues where it accumulates. At clinical doses, gadodiamide primarily affects the T1 relaxation time, thus producing an increase in signal intensity. Gadodiamide does not cross the intact blood-brain barrier; therefore, it does not accumulate in normal brain tissue or in central nervous system (CNS) lesions that have not caused an abnormal blood-brain barrier (e.g., cysts, mature post-operative scars). Abnormal vascularity or disruption of the blood-brain barrier allows accumulation of gadodiamide in lesions such as neoplasms, abscesses, and subacute infarcts.

   

Mangiferin 6'-gallate

[3,4,5-trihydroxy-6-(1,3,6,7-tetrahydroxy-9-oxo-9H-xanthen-2-yl)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C26H22O15 (574.0958662)


   

Tetraphenyl 1,3-phenylene bis(phosphate)

Tetraphenyl 1,3-phenylene bis(phosphate)

C30H24O8P2 (574.0946364)


   

Gadodiamide

Gadodiamide hydrate

C16H26GdN5O8 (574.1022406000001)


V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media

   

NAPHTHOL AS-BI N-ACETYL-BETA-D-GLUCOSAMINIDE

NAPHTHOL AS-BI N-ACETYL-BETA-D-GLUCOSAMINIDE

C26H27BrN2O8 (574.0950682)


   

Phthalocyanine Chloroaluminum

Phthalocyanine Chloroaluminum

C32H16AlClN8 (574.1001796)


   

Mangiferin 6-gallate

Mangiferin 6-gallate

C26H22O15 (574.0958662)


   

[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(1,3,6,7-tetrahydroxy-9-oxoxanthen-2-yl)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(1,3,6,7-tetrahydroxy-9-oxoxanthen-2-yl)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

C26H22O15 (574.0958662)


   

3-[(6-amino-2,4-dihydroxy-4,5,6,7-tetrahydro-3h-azepin-3-yl)-c-hydroxycarbonimidoyl]-3-[({3-[carboxy(chloro)methyl]-2-chloro-2-(1-chloro-3-hydroxybutyl)cyclopropyl}(hydroxy)methylidene)amino]propanoic acid

3-[(6-amino-2,4-dihydroxy-4,5,6,7-tetrahydro-3h-azepin-3-yl)-c-hydroxycarbonimidoyl]-3-[({3-[carboxy(chloro)methyl]-2-chloro-2-(1-chloro-3-hydroxybutyl)cyclopropyl}(hydroxy)methylidene)amino]propanoic acid

C20H29Cl3N4O9 (574.1000034)